Medicine & Life Sciences
Nanoparticles
100%
HIV-1
77%
Pharmacokinetics
68%
GS-7340
53%
JTK 303
52%
HIV
44%
Pharmaceutical Preparations
42%
Aminoglycosides
39%
Rilpivirine
37%
bictegravir
33%
Pre-Exposure Prophylaxis
32%
Therapeutics
29%
HIV Infections
29%
Tenofovir
27%
Emtricitabine
27%
Antimicrobial Stewardship
26%
Macrophages
25%
Indinavir
24%
emtricitabine tenofovir alafenamide
23%
Hospitalization
23%
efavirenz
21%
Virus Diseases
20%
Chronic Bronchitis
20%
Cerebrospinal Fluid
19%
Costs and Cost Analysis
19%
Reverse Transcriptase Inhibitors
18%
Pharmacy Students
18%
Foams and Jellies Vaginal Creams
18%
Lidocaine
17%
Pneumococcal Meningitis
17%
Drug Delivery Systems
16%
Tissue Distribution
16%
Lopinavir
15%
Pharmacy
15%
Drug Combinations
14%
Infections
14%
indole
14%
Students
14%
Fluoroquinolones
14%
Length of Stay
14%
Polylactic Acid-Polyglycolic Acid Copolymer
14%
A 80556
13%
Nontuberculous Mycobacteria
13%
SC 36602
13%
Area Under Curve
13%
Cardiac Arrhythmias
13%
Drug Monitoring
13%
Ritonavir
13%
Dopaminergic Neurons
12%
Endocarditis
12%
Chemical Compounds
Antiretroviral
64%
Tenofovir Alafenamide
48%
Elvitegravir
47%
Emtricitabine
41%
Rilpivirine
31%
Drug
29%
Nanoparticle
27%
Dolutegravir
19%
Pharmacokinetics
18%
Simeprevir
11%
Cellulose Acetate Phthalate
10%
Plasma
10%
Sofosbuvir
9%
Lopinavir
9%
Amino Acid Receptor Affecting Agent
9%
Ritonavir
8%
Ceftriaxone
8%
Prey Cleavage
8%
Anti Hepatitis
8%
Pharmaceutical
8%
Plasma Method
8%
Prostanoid
8%
Acetate
7%
Hematocrit
7%
Mandelic Acid
7%
Aminoglycoside
7%
Formic Acid
7%
Reversed Phase HPLC
7%
Indinavir
6%
Retinal
6%
Beta-Lactam
6%
Acetamide
6%
Nanocarrier
6%
Polyphenol
5%
Insulin Derivative
5%
Error
5%
Pyrrole
5%
Aminoglycoside Antibiotic Agent
5%